Lesson plan
Bleomycin
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 401932982 | image = Bleomycin A2.svg | image_class = skin-invert-image | caption = Bleomycin A2 | width = 350 | alt = | pronounce = | tradename = Blenoxane | Drugs.com = | MedlinePlus = a682125 | DailyMedID = Bleomycin | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = intravenous, intramuscular, subcutaneous, intrapleural | class = Glycopeptide antibiotic | ATC_prefix = L01 | ATC_suffix = DC01 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = | bioavailability = 100% and 70% following intramuscular and subcutaneous administrations, respectively, and 45% following both intraperitoneal and intrapleural administrations | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = two hours | duration_of_action = | excretion = Kidney (60–70%) | index_label = | index2_label = sulfate | CAS_number_Ref = | CAS_number = 11056-06-7 | CAS_number2_Ref = | CAS_number2 = 9041-93-4 | UNII_Ref = | UNII = 40S1VHN69B | PubChem = 5460769…
Article summary
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 401932982 | image = Bleomycin A2.svg | image_class = skin-invert-image | caption = Bleomycin A2 | width = 350 | alt = | pronounce = | tradename = Blenoxane | Drugs.com = | MedlinePlus = a682125 | DailyMedID = Bleomycin | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = intravenous, intramuscular, subcutaneous, intrapleural | class = Glycopeptide antibiotic | ATC_prefix = L01 | ATC_suffix = DC01 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = | bioavailability = 100% and 70% following intramuscular and subcutaneous administrations, respectively, and 45% following both intraperitoneal and intrapleural administrations | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = two hours | duration_of_action = | excretion = Kidney (60–70%) | index_label = | index2_label = sulfate | CAS_number_Ref = | CAS_number = 11056-06-7 | CAS_number2_Ref = | CAS_number2 = 9041-93-4 | UNII_Ref = | UNII = 40S1VHN69B | PubChem = 5460769…
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.